Article: Re:GEN Open, dynamic new peer-reviewed open access journal

Access, Document, Open Decision-Support, Research

Re:GEN Open, dynamic new peer-reviewed open access journal

Mary Ann Liebert, Inc., publishers and Genetic Engineering & Biotechnology News (GEN) announce the launch of Re:GEN Open, the new multidisciplinary open access journal for scientifically rigorous research in the life and medical sciences.

Re:GEN Open combines the dynamic, global media presence of GEN with the scientific peer-reviewed publishing expertise of Mary Ann Liebert, Inc. to deliver an unprecedented publishing experience: best-in-class author services, rapid and fair peer review, and international exposure across the leading media platforms in the industry.

Read Full Article

Article: Progress in Cell-SELEX compound screening technology reviewed in BioResearch Open Access

Access, Document, Open Decision-Support, Research

Progress in Cell-SELEX compound screening technology reviewed in BioResearch Open Access

SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc. The article is available free on the BioResearch Open Access website.

Cell-SELEX uses live cells as targets for binding of molecules called aptamers, comprised of short chains of nucleic acids. Aptamers share many of the qualities that have made antibodies such successful drugs, but offer additional advantages such as stability, short length, and ease of manufacturing.

Read Full Article